Department of Radiology
Found 73 results
Filters: Author is Mosconi, Lisa  [Clear All Filters]
2009
Glodzik L, de Santi S, Rich KE, Brys M, Pirraglia E, Mistur R, Switalski R, Mosconi L, Sadowski M, Zetterberg H et al..  2009.  Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology.. J Alzheimers Dis. 18(3):509-13.
Glodzik-Sobanska L, Pirraglia E, Brys M, de Santi S, Mosconi L, Rich KE, Switalski R, Louis LSaint, Sadowski MJ, Martiniuk F et al..  2009.  The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.. Neurobiol Aging. 30(5):672-81.
Zhan J, Brys M, Glodzik L, Tsui W, Javier E, Wegiel J, Kuchna I, Pirraglia E, Li Y, Mosconi L et al..  2009.  An entorhinal cortex sulcal pattern is associated with Alzheimer's disease.. Hum Brain Mapp. 30(3):874-82.
Mosconi L, Mistur R, Switalski R, Tsui WHon, Glodzik L, Li Y, Pirraglia E, de Santi S, Reisberg B, Wisniewski T et al..  2009.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 36(5):811-22.
Brys M, Glodzik L, Mosconi L, Switalski R, de Santi S, Pirraglia E, Rich K, Kim BC, Mehta P, Zinkowski R et al..  2009.  Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.. J Alzheimers Dis. 16(2):351-62.
Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, Glodzik-Sobanska L, de Santi S, Zinkowski R, Mehta P et al..  2009.  Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.. Neurobiol Aging. 30(5):682-90.
2008
Mosconi L, Pupi A, de Leon MJ.  2008.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.. Ann N Y Acad Sci. 1147:180-95.
Mosconi L, de Santi S, Li J, Tsui WHon, Li Y, Boppana M, Laska E, Rusinek H, de Leon MJ.  2008.  Hippocampal hypometabolism predicts cognitive decline from normal aging.. Neurobiol Aging. 29(5):676-92.
Mosconi L, de Santi S, Brys M, Tsui WH, Pirraglia E, Glodzik-Sobanska L, Rich KE, Switalski R, Mehta PD, Pratico D et al..  2008.  Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.. Biol Psychiatry. 63(6):609-18.
Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S et al..  2008.  Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.. J Nucl Med. 49(3):390-8.
Sigurdsson EM, Wadghiri YZ, Mosconi L, Blind JA, Knudsen E, Asuni A, Scholtzova H, Tsui WH, Li Y, Sadowski M et al..  2008.  A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.. Neurobiol Aging. 29(6):836-47.
Reisberg B, Prichep L, Mosconi L, E John R, Glodzik-Sobanska L, Boksay I, Monteiro I, Torossian C, Vedvyas A, Ashraf N et al..  2008.  The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease.. Alzheimers Dement. 4(1 Suppl 1):S98-S108.
Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Någren K, Kim B-C, Tsui W et al..  2008.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 35(12):2169-81.
de Santi S, Pirraglia E, Barr W, Babb J, Williams S, Rogers K, Glodzik L, Brys M, Mosconi L, Reisberg B et al..  2008.  Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.. Neuropsychology. 22(4):469-84.
2007
Mosconi L, Tsui WHon, Pupi A, de Santi S, Drzezga A, Minoshima S, de Leon MJ.  2007.  (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.. J Nucl Med. 48(7):1129-34.
Mosconi L, Brys M, Glodzik-Sobanska L, de Santi S, Rusinek H, de Leon MJ.  2007.  Early detection of Alzheimer's disease using neuroimaging.. Exp Gerontol. 42(1-2):129-38.
Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, de Santi S, de Leon MJ.  2007.  Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.. Proc Natl Acad Sci U S A. 104(48):19067-72.
Mosconi L, Tsui WH, Rusinek H, de Santi S, Li Y, Wang G-J, Pupi A, Fowler J, de Leon MJ.  2007.  Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 34(9):1467-79.
de Leon MJ, Mosconi L, Logan J.  2007.  Seeing what Alzheimer saw.. Nat Med. 13(2):129-31.
2006
Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M et al..  2006.  Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.. J Nucl Med. 47(11):1778-86.
Mosconi L, de Santi S, Li Y, Li J, Zhan J, Tsui WHon, Boppana M, Pupi A, de Leon MJ.  2006.  Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.. Eur J Nucl Med Mol Imaging. 33(2):210-21.
2005
Glodzik-Sobanska L, Rusinek H, Mosconi L, Li Y, Zhan J, de Santi S, Convit A, Rich K, Brys M, de Leon MJ.  2005.  The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease.. Neuroimaging Clin N Am. 15(4):803-26,x.
2004
Mosconi L, de Santi S, Rusinek H, Convit A, de Leon MJ.  2004.  Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.. Expert Rev Neurother. 4(5):831-49.